Washington, DC - The U.S. Food and Drug Administration today allowed marketing of the Eclipse System for the treatment of fecal incontinence (FI) in adult women.

Washington, DC - The FDA today cleared the Cepheid Xpert MTB/RIF Assay to help physicians determine if patients with suspected tuberculosis (TB) can be removed from airborne infection isolation. This expanded use allows healthcare providers to use one or two negative Xpert MTB/RIF Assay test results to help them determine whether a patient showing signs and symptoms of pulmonary TB should continue to be kept in a hospital airborne isolation room.

Sacramento, California - The California Department of Public Health (CDPH) issued 10 penalties today to 10 California hospitals along with fines totaling $700,000 after investigations found the facilities’ noncompliance with licensing requirements caused, or was likely to cause, serious injury or death to patients.

West Lafayette, Indiana - Purdue University research shows that standard cleaning procedures in retail delis may not eradicate Listeria monocytogenes bacteria, which can cause a potentially fatal disease in people with vulnerable immune systems.

Washington, DC - Today, approximately 10 months since the first U.S. personnel deployed to West Africa to fight Ebola, we mark important milestones in our response to the epidemic and chart the way ahead.

West Lafayette, Indiana - A new, relatively simple process makes it possible to create biocompatible particles called shape-controllable microgels that could be custom-designed for specific roles such as drug delivery vehicles, tissue engineering building blocks and biomedical research.